男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Expert: SARS vaccine good so far
(Xinhua)
Updated: 2004-11-28 08:53

Volunteers receiving severe acute respiratory syndrome (SARS) vaccine in a clinical test show no obvious signs of side effects so far, said Zhong Nanshan, an academician of the Chinese Academy of Engineering, at an international seminar held Saturday.

Zhong said that the results of the research will be released inJanuary 2005 after researches determine the effectiveness of the vaccine.

From May to August this year, 36 volunteers received China's first SARS vaccine at another clinical test. Eighteen of them received an injection of low-dosage SARS inactivated vaccine whilethe other 18 received a high dosage. Except for symptoms of side effects of the drug such as fever and discomfort, volunteers showed no other adverse reactions and their health was in good condition.

The antibody in volunteers' blood serum has increased by various levels, but the effectiveness of the vaccine is yet to be verified, said Zhong.

Zhong said there is little chance of another serious SARS outbreak in China as long as labs and wild animals are managed correctly and the four "early" measures are enforced. The measures are: early detection, early report, early isolation and early treatment.

Beginning this year, the country has improved its management oflabs doing SARS research, and banned the sales and consumption of civet cats, said Zhong.

Close

Today's Top News     Top China News
Ukraine parliament calls disputed election invalid         Regulations passed to prevent virus spread         Black boxes decoded, cause still unclear         WTO lets EU, others hit US with sanctions         Eight students slain; attacker arrested         People need better AIDS, HIV information	Bus crash kills 26, injures 46 in Shaanxi       Students need support to boost their start-ups       Graduates compete for government posts       Cross-border organized crime 'a global threat'       Donors' stem cells save cancer victims       Agriculture still top priority next year